Optimization of 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitriles as orally active, irreversible inhibitors of human epidermal growth factor receptor-2 kinase activity. (Q40457478)
scientific article published on February 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Optimization of 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitriles as orally active, irreversible inhibitors of human epidermal growth factor receptor-2 kinase activity. |
scientific article published on February 2005 |
Statements
1 reference
Optimization of 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitriles as orally active, irreversible inhibitors of human epidermal growth factor receptor-2 kinase activity. (English)
1 reference
Hwei-Ru Tsou
1 reference
Elsebe G Overbeek-Klumpers
1 reference
William A Hallett
1 reference
Marvin F Reich
1 reference
M Brawner Floyd
1 reference
Bernard D Johnson
1 reference
Ronald S Michalak
1 reference
Ramaswamy Nilakantan
1 reference
Carolyn Discafani
1 reference
Jonathan Golas
1 reference
Sridhar K Rabindran
1 reference
Ru Shen
1 reference
Xiaoqing Shi
1 reference
Yu-Fen Wang
1 reference
Janis Upeslacis
1 reference
Allan Wissner
1 reference
1 February 2005
1 reference
1 reference
48
1 reference
4
1 reference
1107-1131
1 reference
Identifiers
1 reference
1 reference